Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial

Eur Urol. 2021 Jun;79(6):889-890. doi: 10.1016/j.eururo.2021.02.011. Epub 2021 Feb 23.

Authors

Matteo Augugliaro¹, Matteo Pepa², Giulia Marvaso³, Barbara Alicja Jereczek-Fossa³

Affiliations

¹ Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
² Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy. Electronic address: matteo.pepa@ieo.it.
³ Division of Radiation Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

PMID: 33632550
DOI: 10.1016/j.eururo.2021.02.011

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Male
Prostatic Neoplasms* / radiotherapy
Prostatic Neoplasms* / surgery
Radiosurgery* / adverse effects